Anmeldung erfolgt in Kürze...
Details werden geladen...
Daxdilimab Reduces Disease Activity in Discoid Lupus Study
The IgG1 monoclonal antibody daxdilimab was associated with a significant drop in disease activity, with a favorable safety profile in patients with moderate-to-severe discoid lupus erythematosus.
Ähnliche Seiten
AbbVIe's Zumilokibart Meets Phase 2 Goal In Atopic Dermatitis Study | 30.09.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/abbvies-zumilokibart-meets-phase-2-goal-in-atopic-dermatitis-study-1036584321
Peripheral Artery Disease Tied to Mortality Post-Transplant
https://www.medscape.com/viewarticle/peripheral-artery-disease-linked-higher-risk-mortality-post-2026a10010bdUpadacitinib and Phototherapy Effective for Vitiligo
https://www.medscape.com/viewarticle/upadacitinib-plus-phototherapy-provides-added-efficacy-2026a10010th
Study suggests skipping sweets during antibiotic treatment may help protect the gut microbiome | EurekAlert!
https://www.eurekalert.org/news-releases/1145587Retatrutide Yields Significant Weight Loss in T2D
https://www.medscape.com/viewarticle/retatrutide-yields-significant-weight-loss-t2d-2026a10010n0